MedWatch

EMA establishes new quality innovation expert group

The new group will support ”innovative approaches” within the development, manufacturing, and quality control of drugs.

Photo: Peter Dejong/AP/Ritzau Scanpix

the European Medicines Agency, EMA, has established a new expert group to ”to support innovative approaches for the development, manufacture, and quality control of medicines for the benefit of patients in the European Union,” the agency writes on its website.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs